Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anastasia Geladaris

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Experimental & Molecular Medicine|February 13, 2026
Microglia-associated progression of multiple sclerosis: target identification and therapeutic engagement in human in vitro modelsAlica Blenkle, Anastasia Geladaris, Martin S Weber
CNS Drugs|September 30, 2022
Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis: Pioneering the Path Towards Treatment of Progression?Anastasia Geladaris, Sebastian Torke, Martin S Weber
International Journal of Molecular Sciences|April 3, 2021
Microglia: The Missing Link to Decipher and Therapeutically Control MS Progression?Anastasia Geladaris, Darius Häusler, Martin S Weber
Trends in Neurosciences|December 15, 2023
Toward identifying key mechanisms of progression in multiple sclerosisLeila Husseini, Anastasia Geladaris, Martin S Weber
Expert Opinion on Therapeutic Targets|June 5, 2023
Bruton's tyrosine kinase as a promising therapeutic target for multiple sclerosisDarius Saberi, Anastasia Geladaris, Sarah Dybowski, et al.
BMC Neuroscience|July 6, 2016
Transnasal delivery of human A-beta peptides elicits impaired learning and memory performance in wild type miceKristina Endres, Sven Reinhardt, Anastasia Geladaris, et al.
Acta Neuropathologica Communications|December 2, 2025
Siponimod inhibits disease-associated microglia-T cell interactions in chronic experimental autoimmune encephalomyelitisLeila Husseini, Anastasia Geladaris, Marlene C J Steinleitner, et al.
Acta Neuropathologica|March 1, 2023
IL-10-providing B cells govern pro-inflammatory activity of macrophages and microglia in CNS autoimmunityAnastasia Geladaris, Silke Häusser-Kinzel, Roxanne Pretzsch, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 25, 2025
Bruton Tyrosine Kinase Inhibition Limits Multiple Sclerosis Disease-Driving Inflammation While Promoting Regulatory B CellsSarah Dybowski, Jacqueline Thode, Marie Freier, et al.
Acta Neuropathologica|April 24, 2024
BTK inhibition limits microglia-perpetuated CNS inflammation and promotes myelin repairAnastasia Geladaris, Sebastian Torke, Darius Saberi, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Experimental & Molecular Medicine|February 13, 2026
Microglia-associated progression of multiple sclerosis: target identification and therapeutic engagement in human in vitro modelsAlica Blenkle, Anastasia Geladaris, Martin S Weber
CNS Drugs|September 30, 2022
Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis: Pioneering the Path Towards Treatment of Progression?Anastasia Geladaris, Sebastian Torke, Martin S Weber
International Journal of Molecular Sciences|April 3, 2021
Microglia: The Missing Link to Decipher and Therapeutically Control MS Progression?Anastasia Geladaris, Darius Häusler, Martin S Weber
Trends in Neurosciences|December 15, 2023
Toward identifying key mechanisms of progression in multiple sclerosisLeila Husseini, Anastasia Geladaris, Martin S Weber
Expert Opinion on Therapeutic Targets|June 5, 2023
Bruton's tyrosine kinase as a promising therapeutic target for multiple sclerosisDarius Saberi, Anastasia Geladaris, Sarah Dybowski, et al.
BMC Neuroscience|July 6, 2016
Transnasal delivery of human A-beta peptides elicits impaired learning and memory performance in wild type miceKristina Endres, Sven Reinhardt, Anastasia Geladaris, et al.
Acta Neuropathologica Communications|December 2, 2025
Siponimod inhibits disease-associated microglia-T cell interactions in chronic experimental autoimmune encephalomyelitisLeila Husseini, Anastasia Geladaris, Marlene C J Steinleitner, et al.
Acta Neuropathologica|March 1, 2023
IL-10-providing B cells govern pro-inflammatory activity of macrophages and microglia in CNS autoimmunityAnastasia Geladaris, Silke Häusser-Kinzel, Roxanne Pretzsch, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 25, 2025
Bruton Tyrosine Kinase Inhibition Limits Multiple Sclerosis Disease-Driving Inflammation While Promoting Regulatory B CellsSarah Dybowski, Jacqueline Thode, Marie Freier, et al.
Acta Neuropathologica|April 24, 2024
BTK inhibition limits microglia-perpetuated CNS inflammation and promotes myelin repairAnastasia Geladaris, Sebastian Torke, Darius Saberi, et al.
Pageof 1